Abstract:Background
The Yes-associated-protein-1 (YAP1) is a novel, direct regulator of stem cell genes both in development and cancer. FAT4 is an upstream regulator that induces YAP1 cytosolic sequestering by phosphorylation (p-Ser 127) and therefore inhibits YAP1-dependent cellular proliferation. We hypothesized that loss of FAT4 signaling would result in expansion of the nephron progenitor population in kidney development and that YAP1 subcellular localization would be dysregulated in Wilms tumor (WT), an embryonal … Show more
“…Based on previous studies, 6,17 we predicted that the decreased ratio of p-Yap/Yap may be due to the nuclear translocation of Yap from the cytoplasm in GC cells. We therefore extracted cytoplasmic proteins and nuclear proteins from GC cell lysates, and assessed the expression levels of Fat4, p-Yap and total Yap.…”
Section: Fat4 Inhibition Enhances the Gc Cell Migrationmentioning
confidence: 90%
“…Whereas these phenotypes may be ascribed to the aberrant ratios of p-Yap/Yap and p-LATS1/LATS1, the underlying pathways dysregulated in GC remain unclear, although Fat4 commonly regulates tissue development via the Hippo pathway. [5][6][7] In order to further understand the mechanism by which Fat4 regulates GC cell proliferation and migration, we investigated the Hippo signaling pathway and interrelated critical elements.…”
Section: Fat4 Inhibition Enhances the Gc Cell Migrationmentioning
confidence: 99%
“…5 Therefore further studies investigating the regulatory mechanisms between Fat4 and the Hippo pathway are necessary. Fat4 plays a critical role in tissue development, for example the kidney, 6 by modulating Yap and modifying Wnt9b/b-catenin thereby regulating the differentiation of progenitors and renewal program of the kidney. 7 In addition, Fat4 interacts with PCP pathway proteins and disrupts oriented cell division, leading to dysfunction of multiple organs including the renal cyst, neural tube and inner ear.…”
Section: Introductionmentioning
confidence: 99%
“…18 Mutations in Fat4 are considered as a major cause of reduced expression, and lead to the aberrant activation of Yap and its translocation into the nucleus. 6,17 Intriguingly, cytoplasmic Yap was reported to suppress Wnt/b-catenin signaling via binding and preventing b-catenin nuclear translocation. 19 In the contrast, however, Rosenbluh and colleagues 20 found that Yap1 exists in a complex with b-catenin sustaining the survival and transformation of b-catenin dependent cancers.…”
Fat4 functions as a Hippo signaling regulator which is involved in mammalian tissue development, differentiation and tumorigenesis. Loss of Fat4 due to frequent gene mutation was detected in a variety of tumors including gastric cancer, where Fat4 was recognized as a tumor suppressor, repressing cancer cell proliferation and adhesion. However, the detailed mechanisms linking Fat4 to its diverse functions and clinicopathological characteristics in gastric cancer remain unclear. Here, we silenced Fat4 using Fat4-shRNA in gastric cancer cells and found that this suppression led to the increase in phosphorylated Yap and nuclear accumulation of Yap, which associated to the promoted proliferation, migration and cell cycle progression. Then we transfected a full-length Fat4 into the Fat4-silenced cells, and found the decrease in phosphorylated Yap and inhibition of the cell cycle progression. Intriguingly, Fat4 reduction also leads to the accumulation of cytoplasmic b-catenin via the loss of restraining to cytoplasmic Yap instead of b-catenin transcription promotion. The Fat4-silenced cells which were treated with 5-FU, Cisplatin, Oxaliplatin and Paclitaxel individually demonstrated less sensitivities to these chemotherapy drugs compared with the control cells. Furthermore, immunohistochemical analysis revealed that Fat4 expression was significantly reduced in gastric cancer tissues compared with adjacent noncancerous tissues, and negatively correlated with tumor infiltration, lymph node metastasis and cumulative survival rate. In conclusion, Fat4 expression is deceased in gastric cancer cells, leading to nuclear translocation of Yap and correlates with poor prognosis.
“…Based on previous studies, 6,17 we predicted that the decreased ratio of p-Yap/Yap may be due to the nuclear translocation of Yap from the cytoplasm in GC cells. We therefore extracted cytoplasmic proteins and nuclear proteins from GC cell lysates, and assessed the expression levels of Fat4, p-Yap and total Yap.…”
Section: Fat4 Inhibition Enhances the Gc Cell Migrationmentioning
confidence: 90%
“…Whereas these phenotypes may be ascribed to the aberrant ratios of p-Yap/Yap and p-LATS1/LATS1, the underlying pathways dysregulated in GC remain unclear, although Fat4 commonly regulates tissue development via the Hippo pathway. [5][6][7] In order to further understand the mechanism by which Fat4 regulates GC cell proliferation and migration, we investigated the Hippo signaling pathway and interrelated critical elements.…”
Section: Fat4 Inhibition Enhances the Gc Cell Migrationmentioning
confidence: 99%
“…5 Therefore further studies investigating the regulatory mechanisms between Fat4 and the Hippo pathway are necessary. Fat4 plays a critical role in tissue development, for example the kidney, 6 by modulating Yap and modifying Wnt9b/b-catenin thereby regulating the differentiation of progenitors and renewal program of the kidney. 7 In addition, Fat4 interacts with PCP pathway proteins and disrupts oriented cell division, leading to dysfunction of multiple organs including the renal cyst, neural tube and inner ear.…”
Section: Introductionmentioning
confidence: 99%
“…18 Mutations in Fat4 are considered as a major cause of reduced expression, and lead to the aberrant activation of Yap and its translocation into the nucleus. 6,17 Intriguingly, cytoplasmic Yap was reported to suppress Wnt/b-catenin signaling via binding and preventing b-catenin nuclear translocation. 19 In the contrast, however, Rosenbluh and colleagues 20 found that Yap1 exists in a complex with b-catenin sustaining the survival and transformation of b-catenin dependent cancers.…”
Fat4 functions as a Hippo signaling regulator which is involved in mammalian tissue development, differentiation and tumorigenesis. Loss of Fat4 due to frequent gene mutation was detected in a variety of tumors including gastric cancer, where Fat4 was recognized as a tumor suppressor, repressing cancer cell proliferation and adhesion. However, the detailed mechanisms linking Fat4 to its diverse functions and clinicopathological characteristics in gastric cancer remain unclear. Here, we silenced Fat4 using Fat4-shRNA in gastric cancer cells and found that this suppression led to the increase in phosphorylated Yap and nuclear accumulation of Yap, which associated to the promoted proliferation, migration and cell cycle progression. Then we transfected a full-length Fat4 into the Fat4-silenced cells, and found the decrease in phosphorylated Yap and inhibition of the cell cycle progression. Intriguingly, Fat4 reduction also leads to the accumulation of cytoplasmic b-catenin via the loss of restraining to cytoplasmic Yap instead of b-catenin transcription promotion. The Fat4-silenced cells which were treated with 5-FU, Cisplatin, Oxaliplatin and Paclitaxel individually demonstrated less sensitivities to these chemotherapy drugs compared with the control cells. Furthermore, immunohistochemical analysis revealed that Fat4 expression was significantly reduced in gastric cancer tissues compared with adjacent noncancerous tissues, and negatively correlated with tumor infiltration, lymph node metastasis and cumulative survival rate. In conclusion, Fat4 expression is deceased in gastric cancer cells, leading to nuclear translocation of Yap and correlates with poor prognosis.
“…on A-type lamins or emerin; Ho et al, 2013;Swift et al, 2013b) or, conceivably, by protein modifications (e.g. YAP1 nuclear localization can be stimulated by phosphorylation of the protein; Murphy et al, 2014). Additionally, transient breakdown of the nuclear envelope in laminopathic cells, perhaps as a consequence of a reduced robustness under conditions of mechanical stress, has been shown to allow the ingress of transcription factors such as RelA (De Vos et al, 2011).…”
Section: Mechanotransduction To the Nucleus -Downstream Of Ecm And Laminmentioning
How cells respond to physical cues in order to meet and withstand the physical demands of their immediate surroundings has been of great interest for many years, with current research efforts focused on mechanisms that transduce signals into gene expression. Pathways that mechano-regulate the entry of transcription factors into the cell nucleus are emerging, and our most recent studies show that the mechanical properties of the nucleus itself are actively controlled in response to the elasticity of the extracellular matrix (ECM) in both mature and developing tissue. In this Commentary, we review the mechano-responsive properties of nuclei as determined by the intermediate filament lamin proteins that line the inside of the nuclear envelope and that also impact upon transcription factor entry and broader epigenetic mechanisms. We summarize the signaling pathways that regulate lamin levels and cell-fate decisions in response to a combination of ECM mechanics and molecular cues. We will also discuss recent work that highlights the importance of nuclear mechanics in niche anchorage and cell motility during development, hematopoietic differentiation and cancer metastasis, as well as emphasizing a role for nuclear mechanics in protecting chromatin from stress-induced damage.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.